This inventor holds 1 USPTO granted patent. Top assignee: University Of Louisville Research Foundation, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations in Cognitive Diagnosis by Fatmaelzahraa El-Gamal
Introduction
Fatmaelzahraa El-Gamal is an accomplished inventor based in Mansoura, Egypt. He has made significant contributions to the field of medical diagnostics, particularly in the area of cognitive impairment. His innovative work focuses on developing advanced systems that aid in the early detection of conditions that may lead to Alzheimer's disease.
Latest Patents
El-Gamal holds a patent for a "Computer Aided Diagnosis System for Mild Cognitive Impairment." This non-invasive system generates a diagnosis of mild cognitive impairment, which is a precursor to Alzheimer's disease. The system utilizes functional positron emission tomography and structural magnetic resonance imaging data to reconstruct a model of the patient's cortex. It employs machine-learning techniques to generate probabilities for mild cognitive impairments in local cortical regions. Furthermore, it fuses local diagnoses to create a global diagnosis based on each imaging modality, ultimately leading to a final global diagnosis.
Career Highlights
El-Gamal is associated with the University of Louisville Research Foundation, Inc., where he continues to advance his research in cognitive diagnostics. His work is pivotal in enhancing the accuracy and efficiency of diagnosing cognitive impairments, which can significantly impact patient care and treatment options.
Collaborations
He collaborates with notable colleagues such as Ayman Sabry El-Baz and Mohammed Elmogy, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Fatmaelzahraa El-Gamal's contributions to the field of cognitive diagnosis exemplify the importance of innovation in medical technology. His patented system represents a significant step forward in the early detection of cognitive impairments, ultimately benefiting patients and healthcare providers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
